Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,550 people get STJ articles and Market Currents by email alert.
Get email alerts on STJ »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
Boston Scientific Could Benefit From St. Jude Medical's TroublesTrefis • Tue, Nov 27, 2012 -
-
-
Why St. Jude Is Poised To Become A Solid Income StockValuentum • Thu, Sep 20, 2012
-
St. Jude Medical's Weaker Guidance Presents Another OpportunityStephen Simpson • Wed, Jul 18, 2012
-
-
-
-
-
-
St. Jude Medical: Earnings PreviewZacks Investment Research • Wed, Jan 25, 2012
-
Quality, With A Dividend, Now On Sale: St. Jude MedicalK202 • Tue, Jan 10, 2012 -
St. Jude Remains On Our Dividend Growth Watch ListValuentum • Wed, Jan 4, 2012
To learn more about Seeking Alpha Pro, click here.
-
St. Jude Medical Inc. - Analyst/Investor DayFri, Feb 3, 2012
-
St. Jude Medical Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
St. Jude Medical Inc. Q1 2010 Earnings Call TranscriptWed, Apr 21, 2010
-
St. Jude Medical Inc. Q4 2009 Earnings Call TranscriptWed, Jan 27, 2010
-
St. Jude Medical Inc., Q3 2009 Earnings Call TranscriptWed, Oct 21, 2009
-
St. Jude Medical, Inc. Q2 2009 Earnings Call TranscriptWed, Jul 22, 2009
-
St. Jude Medical, Inc. Q1 2009 Earnings Call TranscriptWed, Apr 22, 2009 • 1 Comment
-
Business Wire (Jun 11, 2013)
-
Business Wire (Jun 7, 2013)
-
at MarketWatch.com (May 23, 2013)
-
Business Wire (May 21, 2013)
-
Business Wire (May 21, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 17, 2013)
-
at CNBC.com (Apr 14, 2013)
-
at CNBC.com (Apr 9, 2013)
-
Business Wire (Apr 4, 2013)
STJ vs. ETF Alternatives
Company Description
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. Our four operating... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, June 12, 1:07 PM Deutsche Bank (Buy) thinks the approval of St. Jude Medical's (STJ +2.6%) implantable cardioverter and cardiac resynchronization defibrillators is a "good sign," as it may signal that STJ is "making progress" with its efforts to allay concerns tied to an FDA inspection of the company's Sylmar, California manufacturing facility. Wedbush's Tao Levy concurs, noting that the FDA "viewed the safety enhancements of the Ellipse and Assura as important enough to approve despite the warning letter." Comment! [On the Move, Healthcare]
- Tuesday, June 11, 4:47 PM St. Jude Medical (STJ) says it's received FDA approval for its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery. Comment! [Healthcare]
- Friday, May 31, 10:53 AM Wedbush initiates several medical equipment and supply names. Rundown: Boston Scientific (BSX +0.8%), which is "progressing with its turnaround story," is started at Neutral (price target $10) with new product intros serving as "catalysts for higher EPS"; Medtronic (MDT) is started at Neutral (price target $52) and is "an 800-lb. gorilla [facing] growing competition, limited near-term growth, and an overextended valuation"; St. Jude Medical (STJ -0.9%) is started at Outperform (price target $57) as the Durata overhang "is beginning to lose some steam enabling investors to refocus on STJ's healthy pipeline." 1 Comment [Healthcare]
- Tuesday, May 28, 8:43 AM Canaccord downgrades St. Jude Medical (STJ) to Sell citing "questionable earnings quality," a less-than-enthusiastic take on the company's product pipeline, the potential for CRM market share loss, and an "overextended valuation." Price target maintained at $35. 1 Comment [Healthcare]
- Thursday, May 2, 2:56 PM St. Jude Medical, Inc. (STJ) declares $0.25/share quarterly dividend, in line with previous. Forward yield 2.46%. For shareholders of record June 28. Payable July 31. Ex-div date June 26. (PR) Comment! [Dividends]
- Wednesday, April 17, 5:50 PM Volcano (VOLC) files a lawsuit against St. Jude Medical (STJ) for patent infringement, accusing STJ of violating its patent on certain guide wire methods used in its devices. The suit is just another salvo in an ongoing patent war between the two companies over pressure wire technology used their heart devices. The war actually began nearly three years ago, when STJ filed suit against VOLC for infringement of 5 of its own patents for pressure guide wire products. Comment! [Healthcare]
- Wednesday, April 17, 8:20 AM From St. Jude's (STJ) earnings call. Lowers 2013 sales guidance to $5.36-5.48B, representing a cut of $107M at the midpoint. Analysts expect $5.7B. The lower forecast is due to changes in currency assumptions and a more cautious outlook in its cardiovascular business. Expects currency neutral sales growth of -1% to +2%. (Q1 earnings) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, April 17, 8:10 AM More on St. Jude Medical (STJ) Q1: net profit +5% to $223M, with the company enjoying a $21M tax benefit but taking $61M in charges, primarily related to restructuring and acquisition activities. Forex fluctuations hurt sales by $17M. Sales breakdown: Cardiac Rhythm Management -8% to $678M; Atrial Fibrillation +5% to $233M; total cardiovascular sales -2% to $328M. Expects Q2 EPS of $0.93-$0.95 vs consensus of 0.94 and FY EPS of $3.68-$3.73 vs $3.95. (PR) Comment! [Earnings]
- Wednesday, April 17, 7:31 AM St. Jude Medical (STJ): Q1 EPS of $0.92 beats by $0.01. Revenue of $1.34B (-4% Y/Y) misses by $0.02B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, April 17, 12:05 AM Notable earnings before Wednesday’s open: ABT, ASML, BAC, BK, DGX, DOV, FCFS, HBAN, MAT, PNC, STJ, TXT Comment! [Earnings]
- Tuesday, April 16, 5:30 PM Notable earnings before Wednesday’s open: ABT, ASML, BAC, BK, DGX, DOV, FCFS, HBAN, MAT, PNC, STJ, TXT Comment! [Earnings]
- Friday, April 5, 5:00 AM St. Jude Medical (STJ) has been hit with lawsuits in California that allege that defects with the manufacturing and oversight of its now recalled Riata heart defibrillator "leads" injured or killed over 30 patients. The suits could have a wider impact, as they seek to get round a 2008 Supreme Court ruling that protected medical-device companies from product-liability claims as long as they complied with FDA standards. Comment! [Healthcare]
- Friday, March 8, 2:55 PM St. Jude Medical (STJ +1.1%) is up today after the company reports the first patient implant in a new trial evaluating the company's Aplatzer Cardiac Plug, a device for the prevention of stroke. The trial is designed to determine if the device is safe and effective in preventing thrombus from migrating out of the left atrial appendage in patients with non-valvular atrial fibrillation who have a high risk for stroke. Comment! [Healthcare, On the Move]
- Monday, February 25, 8:57 AM St. Jude Medical, Inc. (STJ) declares $0.25/share quarterly dividend, 9% increase from prior dividend of $0.23. Forward yield 2.43%. For shareholders of record Mar. 29. Payable Apr. 30. Ex-div date Mar. 27. (PR) Comment! [Dividends]
- Friday, February 15, 2:10 PM St. Jude Medical (STJ -3.4%) has been working overtime to convince the Street that its Durata heart device leads are safe, but Cowen doesn't take the bait, downgrading the stock to Market Underperform over concerns that the new heart wire is no different from the ones already taken off the market. The firm cites a "significant risk" of a recall, which would " meaningfully damage" its defibrillator and pacemaker business. Comment! [Healthcare, On the Move]
-
Wednesday, February 13, 9:42 AM
St. Jude Medical (STJ +0.5%) has issued a voluntary Class 1 recall of its Amplatzer TorqVue FX Delivery System, which is used for hole in the heart surgery, after the company discovered that the device could fracture in a number of cases, causing serious damage and even death. However, no serious injuries have occurred.
Comment! [Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.